Imported death penalty drug to be tested by FDA

The anesthetic sodium thiopental purchased by California prison officials from a U.K. manufacturer will be tested by the FDA prior to use. It was shipped to the U.S. before the U.K. decided last month to constrain export of the drug to prevent its use in executions.

Counting the U.K. shipment, California says it has enough of the drug for 175 executions. More than 700 inmates populate death row in the Golden State.

Officials augmented their $36,000 purchase of 521 grams from Archimedes Pharma with 12 grams provided at no charge by the Arizona penal system.

Sodium thiopental has been in short supply in the U.S. due primarily to manufacturing delays at drugmaker Hospira, following an FDA warning for GMP violations at a North Carolina facility, as reported.  The company projects greater availability of the drug early next year.

- see the article

Suggested Articles

Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects.

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.